CCCS(CCCS)
CCCS
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.15B | $1.25B |
| Low | $1.13B | $1.25B |
| High | $1.16B | $1.25B |
| EBITDA Avg | $182M | $197M |
| Low | $179M | $197M |
| High | $184M | $197M |
| EBIT Avg | $-5M | $-5M |
| Low | $-5M | $-5M |
| High | $-5M | $-5M |
| Net Income Avg | $279M | $307M |
| Low | $266M | $156M |
| High | $292M | $458M |
| EPS Avg | $0.41 | $0.47 |
| Low | $0.40 | $0.24 |
| High | $0.44 | $0.69 |
| Analysts (Rev / EPS) | 10 / 7 | 8 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $285M | $293M | $300M | $297M | $309M | $320M | $322M |
| Low | $285M | $293M | $300M | $297M | $309M | $320M | $322M |
| High | $285M | $293M | $300M | $297M | $309M | $320M | $322M |
| EBITDA Avg | $45M | $46M | $47M | $47M | $49M | $51M | $51M |
| Low | $45M | $46M | $47M | $47M | $49M | $51M | $51M |
| High | $45M | $46M | $47M | $47M | $49M | $51M | $51M |
| EBIT Avg | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M |
| Low | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M |
| High | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M | $-1M |
| Net Income Avg | $64M | $65M | $68M | $61M | $70M | $73M | $75M |
| Low | $64M | $65M | $68M | $61M | $70M | $73M | $75M |
| High | $64M | $65M | $68M | $61M | $70M | $73M | $75M |
| EPS Avg | $0.11 | $0.11 | $0.11 | $0.10 | $0.12 | $0.12 | $0.12 |
| Low | $0.11 | $0.11 | $0.11 | $0.10 | $0.12 | $0.12 | $0.12 |
| High | $0.11 | $0.11 | $0.11 | $0.10 | $0.12 | $0.12 | $0.12 |
| Analysts (Rev / EPS) | 5 / 3 | 4 / 3 | 4 / 4 | 4 / 2 | 3 / 2 | 3 / 2 | 3 / 2 |